Clinical Trial Update: Fludarabine Based RIC for Bone Marrow Failure Syndromes [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating fludarabine-based reduced-intensity conditioning for bone marrow failure syndromes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Bone Marrow Failure Syndromes | EARLY_Phase 1 | Status: RECRUITING